medline.ch Respirationstrakt Neoplasie

	Effects of multiple low-dose intranasal dexmedetomidine administration on postoperative pulmonary complications in elderly patients undergoing thoracoscopic radical resection of lung cancer: a single-center randomized controlled trial. Front Pharmacol Li B, Liu Y, Liu X, Han M, Meng X, Sun M, Zhang J, Zhang W. PMID: 42890876 [PubMed]
	Lung cancer screening health beliefs among a high-risk population in China: a cross-sectional survey. Front Public Health Lin X, Wang F, Lin Y, Yang J, Lei F, Huang F. PMID: 42890857 [PubMed - indexed for MEDLINE]
	Treatment context is associated with thrombocytopenia report phenotypes in lung cancer: an active-comparator analysis of FAERS and JADER. Front Immunol Yang F, Jiang Q, Wei Z, Hu T. PMID: 42890849 [PubMed - indexed for MEDLINE]
	Lung microbiota, gut microbiota, and the lung-gut axis in lung cancer immunotherapy: a tripartite regulatory perspective. Front Immunol Chen Q, Wang J, Sun D, Qin J. PMID: 42890693 [PubMed - indexed for MEDLINE]
	Genetic Variants in Inflammatory Response Genes and Lung Cancer Risk: A Case-Control Study. Tanaffos Khosravi A, Seifi S, Salimi B, Mabani M, Rostami P, Nomani M, Seif S, Dezhkhi H, Sadatkiaei SF. PMID: 42890664 [PubMed]
	Molecular Mechanisms and Therapeutic Advances in KRAS G12C-Mutant Non-Small Cell Lung Cancer: Toward Mechanism-Guided Longitudinal Management. Cancer Innov Wang H, Chen H, Li S, Zhao J. PMID: 42890422 [PubMed]
	Galactooligosaccharides Suppress the Development of Biofilm in the Presence of Blood Polymorphonuclear Cells of Non-Small Cell Lung Cancer (NSCLC) Patients: A Pilot Study. Tanaffos Nomani M, Salimi B, Varahram M, Jamaati H, Mortaz E. PMID: 42890051 [PubMed]
	Case Report: Synchronous double primary male breast cancer and non-small cell lung cancer: diagnostic confirmation and multidisciplinary management. Front Med (Lausanne) Zhang Y, Cao L, Zheng Y, Yang Y, Guan X, Zheng X, Yang P, Zhu W. PMID: 42889733 [PubMed]
	Exploring the immune enhancement effect of radiotherapy combined with NK cells on non-small cell lung cancer based on proteomics technology. Oncol Rev Chang C, Youming T, Ying L, Ningning L, Chunhui G, Dekai W, Mei L, Qiyuan W, Gechen L, Fasheng W, Jibing C. PMID: 42889653 [PubMed]
	Successful management of synchronous prostate adenocarcinoma and lung squamous cell carcinoma with sintilimab and ADT in a frail elderly patient with bronchiectasis: a case report. Front Immunol Huang Y, Zhan W, Su T, Liu Y. PMID: 42889325 [PubMed - indexed for MEDLINE]
	Contributions of smoking behaviour to lung cancer subtypes: A two-sample Mendelian randomization study. Medicine (Baltimore) Jareebi MA, Alqassim AY. PMID: 42888622 [PubMed - indexed for MEDLINE]
	Causal relationship between oral microbiome, circulating inflammatory proteins and lung cancer: A Mendelian randomization study. Medicine (Baltimore) Ping S, Li D, Sun J, Tao K, Qin E, Tang R, Shan H, Ye H, He M. PMID: 42888565 [PubMed - indexed for MEDLINE]
	PLCG1 regulates pyroptosis to inhibit the progression of non-small cell lung cancer: A Mendelian randomization study. Medicine (Baltimore) Zhang Y, Wang G, Qin Z, Mo Z, Liu J. PMID: 42888548 [PubMed - indexed for MEDLINE]
	Real-world efficacy and prognostic factor analysis of tislelizumab versus sintilimab in advanced non-small cell lung cancer. BMC Cancer Liu Q, Zhu X, Xie Y, Gu Y, Shen L. PMID: 42888403 [PubMed - indexed for MEDLINE]
	Value and research advances of ctDNA in perioperative therapy for non-small cell lung cancer. Clin Transl Oncol Diao J, Cen F, Gao Y, Jiang M, Yin H. PMID: 42888302 [PubMed - as supplied by publisher]
	Retrospective Lung-RADS v2022 Characterization of Fatal Lung Cancer Cases in the National Lung Screening Trial. Acad Radiol Tanwar A, Ebrahimzadeh S, Vella M, Ahn H, Beagle A, Schnitzler T, Bondarenko M, Yala A, Brown J, Sohn JH. PMID: 42888057 [PubMed - as supplied by publisher]
	Firmonertinib in advanced non-small cell lung cancer with epidermal growth factor receptor P-loop and Î±C-helix compressing mutations. Cancer Cell Le X, Wang J, Yu Y, Zhao Y, Planchard D, Gao B, Spira A, Liu J, Li X, Gadgeel S, Leighl N, Zhang J, Hayashi H, Nishio M, Mazieres J, de Langen AJ, Pérol M, Yoh K, Forster MD, Goto Y, de Miguel Luken M, Franco Perez FF, Chu Q, Parakh S, Nilsson MB, Jiang Y, Hu T, Wang C, Baio N, Musib L, Mounir Z, Kowanetz M, Wang S, Yea S, Hsu J, Lutzker S, Heymach JV, Juan-Vidal O, Riess JW. PMID: 42887497 [PubMed - as supplied by publisher]
	Lazertinib plus pemetrexed and carboplatin in patients with EGFR-mutant advanced non-small cell lung cancer after progression on lazertinib. Eur J Cancer Hong MH, Shim BY, Kim CG, Kim YS, Lee S, Lee Y, Ahn BC, Ahn MJ, Ahn JS, Park S, Yeo JH, Hong SH, Jang IH, Lee KH, Kim HR. PMID: 42887461 [PubMed - as supplied by publisher]
	A Randomized Phase III Trial of Concurrent Chemoradiotherapy Followed by Durvalumab Consolidation, With or Without Induction Chemo-Immunotherapy, in Patients With Unresectable Locally Advanced Non-Small Cell Lung Cancer: JCOG2510 (PRIME-CRT). Clin Lung Cancer Kawabata K, Masuda K, Miura K, Saida Y, Ko R, Akamatsu H, Horinouchi H, Chiba T, Okuma K, Harada H, Shiraishi Y, Goto Y, Nomura S, Mitome N, Fukuda H, Okamoto I, Kenmotsu H, Lung Cancer Study Group of the Japan Clinical Oncology Group. PMID: 42887199 [PubMed - as supplied by publisher]
	Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with early and locally advanced non-small-cell lung cancer. ESMO Open Hayashi H, Zer A, Kenmotsu H, Tachihara M, Cui J, Sutandyo N, Lokeshwar N, Lee GW, Voon PJ, Samala K, Ang MK, Chiu CH, Sriuranpong V, Reungwetwattana T, Liao BC, Soo RA, Ladrera GEI, Alip A, Kim HR, Basade M, Rumende CM, Wang J, Popat S, Lim E, Tsutani Y, Matsuo Y, Minami H, Leighl N. PMID: 42887130 [PubMed - as supplied by publisher]

Artikel 1 - 20 / 163863

Seite 1 von 8194



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung